SAGE Therapeutics (SAGE)
NASDAQ:SAGE
Holding SAGE?
Track your performance easily

SAGE Therapeutics (SAGE) Ownership - Who Owns SAGE Therapeutics?

888 Followers

SAGE Therapeutics (SAGE) Ownership Overview

1.56%23.92%0.86%15.82%57.84%
0.86% Other Institutional Investors
15.82% ETFs
57.84% Public Companies and
Individual Investors
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail, and individual investors. Approximately 40.60% of the company’s stock is owned by Institutional Investors, 1.56% is owned by Insiders, and 57.84% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$536114
Jun 30, 2024
xxxxxxxxxxxxx
$1857342
Jun 30, 2024
xxxxxxxxxxxxx
$4739532

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,498,395Institution7.37%36,032,144
4,062,380Institution6.65%32,539,664
2,616,082Institution4.29%20,954,817
2,584,304Institution4.23%20,700,275
1,661,776Institution2.72%13,310,826
1,259,552Institution2.06%10,089,012
787,874Institution1.29%6,310,871
635,150Institution1.04%5,087,552
599,930Institution0.98%4,805,439
593,111Insider0.97%4,750,819

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,498,395Institution7.37%36,032,144
2,616,082Institution4.29%20,954,817
1,259,552Institution2.06%10,089,012
787,874Institution1.29%6,310,871
635,150Institution1.04%5,087,552
599,930Institution0.98%4,805,439
538,931Institution0.88%4,316,837
531,422Institution0.87%4,256,690
432,675Institution0.71%3,465,727
283,986Institution0.47%2,274,728

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,587,264Institution2.60%12,460,022
1,711,679Institution2.80%12,358,322
1,401,666Institution2.30%11,227,345
841,339Institution1.38%6,074,468
688,604Institution1.13%4,971,721
524,100Institution0.86%4,198,041
355,638Institution0.58%2,848,660
379,069Institution0.62%2,736,878
265,015Institution0.43%2,080,368
250,081Institution0.41%1,805,585

FAQ

Who Owns SAGE Therapeutics (SAGE)?
According to the latest TipRanks data, approximately 0.86% of the company's stock is held by institutional investors, 1.56% is held by insiders, and 57.84% is held by retail investors.
    What percentage of SAGE Therapeutics (SAGE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.86% of SAGE Therapeutics (SAGE) stock is held by institutional investors.
      What percentage of SAGE Therapeutics (SAGE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 57.84% of SAGE Therapeutics (SAGE) stock is held by retail investors.
        Who owns the most shares of SAGE Therapeutics (SAGE)?
        VANGUARD INDEX FUNDS owns the most shares of SAGE Therapeutics (SAGE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis